PortfoliosLab logo
TDOC vs. META
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between TDOC and META is 0.62, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

TDOC vs. META - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Teladoc Health, Inc. (TDOC) and Meta Platforms, Inc. (META). The values are adjusted to include any dividend payments, if applicable.

0.00%200.00%400.00%600.00%800.00%December2025FebruaryMarchAprilMay
-75.16%
591.32%
TDOC
META

Key characteristics

Sharpe Ratio

TDOC:

-0.69

META:

0.75

Sortino Ratio

TDOC:

-0.96

META:

1.32

Omega Ratio

TDOC:

0.90

META:

1.17

Calmar Ratio

TDOC:

-0.46

META:

0.85

Martin Ratio

TDOC:

-1.40

META:

2.66

Ulcer Index

TDOC:

31.84%

META:

10.86%

Daily Std Dev

TDOC:

61.41%

META:

36.15%

Max Drawdown

TDOC:

-97.79%

META:

-76.74%

Current Drawdown

TDOC:

-97.60%

META:

-18.75%

Fundamentals

Market Cap

TDOC:

$1.23B

META:

$1.51T

EPS

TDOC:

-$5.91

META:

$25.55

PEG Ratio

TDOC:

-1.01

META:

1.99

PS Ratio

TDOC:

0.49

META:

8.84

PB Ratio

TDOC:

0.87

META:

8.18

Total Revenue (TTM)

TDOC:

$2.55B

META:

$170.36B

Gross Profit (TTM)

TDOC:

$1.70B

META:

$139.27B

EBITDA (TTM)

TDOC:

-$734.57M

META:

$86.47B

Returns By Period

In the year-to-date period, TDOC achieves a -22.11% return, which is significantly lower than META's 2.23% return.


TDOC

YTD

-22.11%

1M

-1.12%

6M

-25.55%

1Y

-41.97%

5Y*

-47.55%

10Y*

N/A

META

YTD

2.23%

1M

17.15%

6M

1.24%

1Y

27.00%

5Y*

23.20%

10Y*

22.71%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

TDOC vs. META — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TDOC
The Risk-Adjusted Performance Rank of TDOC is 1616
Overall Rank
The Sharpe Ratio Rank of TDOC is 1515
Sharpe Ratio Rank
The Sortino Ratio Rank of TDOC is 1414
Sortino Ratio Rank
The Omega Ratio Rank of TDOC is 1717
Omega Ratio Rank
The Calmar Ratio Rank of TDOC is 2323
Calmar Ratio Rank
The Martin Ratio Rank of TDOC is 1111
Martin Ratio Rank

META
The Risk-Adjusted Performance Rank of META is 7777
Overall Rank
The Sharpe Ratio Rank of META is 7878
Sharpe Ratio Rank
The Sortino Ratio Rank of META is 7474
Sortino Ratio Rank
The Omega Ratio Rank of META is 7272
Omega Ratio Rank
The Calmar Ratio Rank of META is 8282
Calmar Ratio Rank
The Martin Ratio Rank of META is 7878
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

TDOC vs. META - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Teladoc Health, Inc. (TDOC) and Meta Platforms, Inc. (META). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current TDOC Sharpe Ratio is -0.69, which is lower than the META Sharpe Ratio of 0.75. The chart below compares the historical Sharpe Ratios of TDOC and META, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2025FebruaryMarchAprilMay
-0.69
0.75
TDOC
META

Dividends

TDOC vs. META - Dividend Comparison

TDOC has not paid dividends to shareholders, while META's dividend yield for the trailing twelve months is around 0.34%.


TTM2024
TDOC
Teladoc Health, Inc.
0.00%0.00%
META
Meta Platforms, Inc.
0.34%0.34%

Drawdowns

TDOC vs. META - Drawdown Comparison

The maximum TDOC drawdown since its inception was -97.79%, which is greater than META's maximum drawdown of -76.74%. Use the drawdown chart below to compare losses from any high point for TDOC and META. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-97.60%
-18.75%
TDOC
META

Volatility

TDOC vs. META - Volatility Comparison

The current volatility for Teladoc Health, Inc. (TDOC) is 17.99%, while Meta Platforms, Inc. (META) has a volatility of 18.98%. This indicates that TDOC experiences smaller price fluctuations and is considered to be less risky than META based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%December2025FebruaryMarchAprilMay
17.99%
18.98%
TDOC
META

Financials

TDOC vs. META - Financials Comparison

This section allows you to compare key financial metrics between Teladoc Health, Inc. and Meta Platforms, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00B20.00B30.00B40.00B50.00B20212022202320242025
629.37M
42.31B
(TDOC) Total Revenue
(META) Total Revenue
Values in USD except per share items

TDOC vs. META - Profitability Comparison

The chart below illustrates the profitability comparison between Teladoc Health, Inc. and Meta Platforms, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

55.0%60.0%65.0%70.0%75.0%80.0%20212022202320242025
68.7%
82.1%
(TDOC) Gross Margin
(META) Gross Margin
TDOC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Teladoc Health, Inc. reported a gross profit of 432.54M and revenue of 629.37M. Therefore, the gross margin over that period was 68.7%.

META - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Meta Platforms, Inc. reported a gross profit of 34.74B and revenue of 42.31B. Therefore, the gross margin over that period was 82.1%.

TDOC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Teladoc Health, Inc. reported an operating income of -120.61M and revenue of 629.37M, resulting in an operating margin of -19.2%.

META - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Meta Platforms, Inc. reported an operating income of 17.56B and revenue of 42.31B, resulting in an operating margin of 41.5%.

TDOC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Teladoc Health, Inc. reported a net income of -93.01M and revenue of 629.37M, resulting in a net margin of -14.8%.

META - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Meta Platforms, Inc. reported a net income of 16.64B and revenue of 42.31B, resulting in a net margin of 39.3%.